🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. Policosanol

    BRIGHT MINDS BIOSCIENCES INC.

    Hypercholesterolemia

    phase 3 small molecule terminated

    1 trial

  2. Pretomanid

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis, Pulmonary

    phase 3 small molecule completed

    2 trials

  3. Probuphine (buprenorphine implant)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependency

    phase 3 small molecule completed

    1 trial

  4. Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)

    BRIGHT MINDS BIOSCIENCES INC.

    Human Papillomavirus Infection

    phase 3 mab active

    1 trial

  5. Recovery Management Checkups (RMC)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorders

    phase 3 other completed

    1 trial

  6. SAU

    BRIGHT MINDS BIOSCIENCES INC.

    Signs and Symptoms

    phase 3 other completed

    1 trial

  7. SGM-101

    BRIGHT MINDS BIOSCIENCES INC.

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  8. SPT-07A injection

    BRIGHT MINDS BIOSCIENCES INC.

    Stroke, Acute

    phase 3 small molecule active

    1 trial

  9. STAGE-12

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    phase 3 other completed

    1 trial

  10. Standard Brief Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Usage

    phase 3 other completed

    1 trial

  11. Standard Care

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 other completed

    1 trial

  12. Standard Care Intervention (SCI)

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 3 other completed

    1 trial

  13. Tobacco Use Cessation

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    phase 3 other completed

    1 trial

  14. Tobacco Use Disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 other completed

    1 trial

  15. Topiramate + Cognitive Behavioral Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 3 small molecule active

    1 trial

  16. Tramadol

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Withdrawal Syndrome

    phase 3 small molecule completed

    1 trial

  17. Transitional Case Management Study

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 3 other completed

    1 trial

  18. Trazodone

    BRIGHT MINDS BIOSCIENCES INC.

    Poor Quality Sleep

    phase 3 small molecule completed

    1 trial

  19. Treatment as Usual (TAU)

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Addiction

    phase 3 other completed

    1 trial

  20. Truvada

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule completed

    1 trial

  21. Usual Care

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 3 small molecule completed

    1 trial

  22. VIVITROL injection and VIVITROL Placebo Injection , 24 weeks

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine Dependence

    phase 3 small molecule completed

    1 trial

  23. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 3 small molecule completed

    1 trial

  24. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 small molecule completed

    6 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources